Study of Premenstrual Syndrome and Premenstrual Dysphoria

StatusCompleted
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

The 50 most recent of 325 record versions are accounted for below. See every version on ClinicalTrials.gov ↗

  1. 7 versions Re-verified since Apr 7, 2026, no change to tracked fieldsv319-v325
  2. Trial completed
    • Enrollment target: estimated 1600 to confirmed 1569
    • Site details revised
    v318
  3. 42 versions Re-verified since Jul 3, 2024, no change to tracked fieldsv276-v317
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to identify and describe the symptoms of premenstrual syndrome (PMS). Women who experience PMS symptoms will complete clinical interviews, self-rating scales, and evaluations of mood and endocrine function. A subgroup of women with severe PMS (Premenstrual Dysphoric Disorder or PMDD) will be offered additional research studies that focus on: 1) identifying the endocrine changes that may be responsible for changes in mood and behavior during the premenstrual period, 2) evaluating treatments for PMS symptoms, and/or 3) identifying genetic factors in women with and without PMS. Women with recurrent brief depression will also be recruited to serve as a comparison group.
Trial Details
NCT Number NCT00001177
Lead Sponsor National Institute of Mental Health (NIMH)
Conditions
(from sponsor)		 Mood Disorder
Related terms Mood Disorders, Premenstrual Syndrome
Enrollment 1,569 participants
Start Date
Updated on ClinicalTrials.gov